Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 6 | 2024 | 240 | 0.790 |
Why?
|
| Kidney Diseases | 1 | 2025 | 230 | 0.740 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2022 | 2 | 0.730 |
Why?
|
| Proctocolitis | 1 | 2022 | 2 | 0.730 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 5 | 2023 | 24 | 0.700 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 88 | 0.650 |
Why?
|
| Autophagy | 2 | 2024 | 199 | 0.640 |
Why?
|
| Heart Failure | 2 | 2023 | 531 | 0.630 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 501 | 0.600 |
Why?
|
| Obesity | 1 | 2025 | 1204 | 0.490 |
Why?
|
| Carbon Monoxide | 3 | 2024 | 44 | 0.470 |
Why?
|
| Oxidative Stress | 2 | 2021 | 819 | 0.400 |
Why?
|
| Mitochondria | 1 | 2017 | 446 | 0.380 |
Why?
|
| Inflammation | 4 | 2024 | 652 | 0.340 |
Why?
|
| Phagocytosis | 4 | 2024 | 59 | 0.330 |
Why?
|
| HMGA1a Protein | 2 | 2021 | 3 | 0.310 |
Why?
|
| Paracrine Communication | 2 | 2024 | 13 | 0.260 |
Why?
|
| Risk Factors | 2 | 2025 | 4017 | 0.220 |
Why?
|
| Mice | 9 | 2024 | 5982 | 0.220 |
Why?
|
| Receptors, Purinergic | 1 | 2024 | 13 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2021 | 22 | 0.210 |
Why?
|
| Lymphoma | 1 | 2023 | 71 | 0.190 |
Why?
|
| Cardiovascular Agents | 1 | 2022 | 66 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 92 | 0.180 |
Why?
|
| Blood Platelets | 1 | 2024 | 247 | 0.180 |
Why?
|
| Syndecan-2 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Animals | 10 | 2024 | 13526 | 0.180 |
Why?
|
| Prevalence | 1 | 2025 | 1034 | 0.170 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 54 | 0.170 |
Why?
|
| Neutrophils | 4 | 2024 | 153 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 205 | 0.170 |
Why?
|
| Transgenes | 1 | 2021 | 55 | 0.170 |
Why?
|
| Neutropenia | 1 | 2020 | 113 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2024 | 397 | 0.160 |
Why?
|
| Humans | 10 | 2025 | 53230 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2022 | 580 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2018 | 127 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2017 | 24 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 44 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1569 | 0.130 |
Why?
|
| Fetal Therapies | 1 | 2015 | 1 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 211 | 0.120 |
Why?
|
| Lipids | 1 | 2016 | 163 | 0.120 |
Why?
|
| Fetal Diseases | 1 | 2015 | 54 | 0.110 |
Why?
|
| Antioxidants | 1 | 2017 | 264 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 147 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 120 | 0.110 |
Why?
|
| Phenotype | 1 | 2017 | 803 | 0.100 |
Why?
|
| Macrophages | 2 | 2024 | 380 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 561 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1517 | 0.070 |
Why?
|
| Male | 3 | 2022 | 27435 | 0.060 |
Why?
|
| Purinergic Antagonists | 1 | 2024 | 8 | 0.050 |
Why?
|
| Hemostasis | 1 | 2024 | 55 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2023 | 49 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1925 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2023 | 59 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 2023 | 76 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 128 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 189 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2021 | 15 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 250 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 150 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 35 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2021 | 122 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 25 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 336 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 147 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2021 | 35 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5595 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2020 | 69 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 171 | 0.040 |
Why?
|
| Adipocytes | 1 | 2021 | 131 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2021 | 183 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 272 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 600 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2018 | 28 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2018 | 35 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2018 | 73 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 96 | 0.030 |
Why?
|
| Hypotension | 1 | 2018 | 62 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 88 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2024 | 1748 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 203 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 489 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1031 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 327 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 392 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 310 | 0.030 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2015 | 2 | 0.030 |
Why?
|
| Uterus | 1 | 2015 | 81 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 627 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 191 | 0.030 |
Why?
|
| Stem Cells | 1 | 2015 | 189 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1003 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2015 | 910 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 681 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2015 | 350 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2608 | 0.020 |
Why?
|
| Female | 1 | 2015 | 28782 | 0.010 |
Why?
|